Vaccination with a formalin-killed P-fimbriated E. coli whole-cell vaccine prevents renal scarring from pyelonephritis in the non-human primate

By Roberts J.A.   Kaack M.B.   Baskin G.   Svenson S.B.  

Vaccine, Vol. 13, Iss. 1, 1995-01 ,pp. : 11-16

Elsevier

Access to resources Recommend Favorite

The immunogenicity of oral poliomyelitis vaccine in a primary vaccination series at 2, 4 and 6 months given concurrently with Hib, hepatitis B and diphtheria, tetanus and whole-cell pertussis vaccines administered as three separate injections or as a combination pentavalent vaccine

By Hogg K.   Hogg G.  

Vaccine, Vol. 21, Iss. 21, 2003-06 ,pp. : 2906-2910

Elsevier

Access to resources Recommend Favorite

Community-based assessment of safety and immunogenicity of the whole cell plus recombinant B subunit (WC/rBS) oral cholera vaccine in Peru

By Begue R.E.   Castellares G.   Ruiz R.   Hayashi K.E.   Sanchez J.L.   Gotuzzo E.   Oberst R.B.   Taylor D.N.   Svennerholm A.-M.  

Vaccine, Vol. 13, Iss. 7, 1995-01 ,pp. : 691-694

Elsevier

Access to resources Recommend Favorite

Nonhuman primate models to evaluate vaccine safety and immunogenicity

By Kennedy R.C.   Shearer M.H.   Hildebrand W.  

Vaccine, Vol. 15, Iss. 8, 1997-06 ,pp. : 903-908

Elsevier

Access to resources Recommend Favorite

Thirty-five years' experience with the whole-cell pertussis vaccine in France: vaccine strains analysis and immunogenicity

By Njamkepo E.   Rimlinger F.   Thiberge S.   Guiso N.  

Vaccine, Vol. 20, Iss. 9, 2002-01 ,pp. : 1290-1294

Elsevier

Access to resources Recommend Favorite